Newsletter | June 9, 2025

06.09.25 -- Innovative Strategies In Early Commercialization

SPONSOR

Clinical Research As A Delicate Ecosystem

Making the right outsourcing decision can significantly contribute to the success and growth of your program, providing essential support and resources that empower it to thrive in its objectives and endeavors. Entrust that your program is in hands you can rely on, where integrity is paramount, and excellence is the standard.

FEATURED ARTICLE

Innovative Strategies In Early Commercialization: A Leader's Perspective

For small pharmas and biotechs approaching a commercial launch, agility and execution are more valuable than waiting for a perfect plan, writes Melinta Therapeutics CEO John Harlow.

INDUSTRY INSIGHTS

The Science Behind Patient Decision Making In Clinical Trials

Clinical trial decisions are emotional, not purely rational. Behavioral science reveals how framing, trust, emotion, and design shape participation. Empathy and clarity drive better choices.

The Advantages Of Pharmacovigilance Outsourcing At The Local Level

Outsourcing pharmacovigilance tasks can free up local teams for strategic work. Learn how to build effective partnerships by aligning needs, understanding capabilities, and fostering collaboration.

How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma

TargTex CEO Dr. João Seixas and Nanoform CCO Christian Jones presented highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

Nurturing Innovation In Drug Development

Middlesex County, NJ, offers life sciences organizations a deep talent pool, an extensive R&D presence, and dedicated backing by local government investment.

4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials

Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.